Department of Public Health, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Department of Epidemiology, Evidence-Based Medicine and Biostatistics, Kazakhstan's Medical University "KSPH," Almaty, Kazakhstan.
Asian Pac J Cancer Prev. 2022 Aug 1;23(8):2813-2819. doi: 10.31557/APJCP.2022.23.8.2813.
Diagnosis of breast cancer is associated with high psychological distress. There is a lack of studies examining the prevalence of anxiety among newly diagnosed breast cancer patients in Kazakhstan.
This study aims to assess the mean prevalence and associated sociodemographic and clinical factors of anxiety symptoms in women newly diagnosed with breast cancer. It also aims to determine independent predictors of anxiety risk.
An analysis of 162 newly diagnosed breast cancer patients at the oncology institute in Almaty was performed. Data were collected using a structured questionnaire on social, demographic, and clinical information, as well as the Beck Anxiety Inventory. In addition, multiple regression analysis was used to model the relationship between anxiety risk and independent predictors.
The average age of the patients was 54.41 years (SD=8.1; min.-max: 32-75). The majority of the patients were married (52%), employed or self-employed (51%), had children (91%), had a bachelor's or a graduate degree (50%), lived in an urban area (54%), did not drink (41%), did not smoke (67%), did not engage in physical activity (54%), and had social support (91%). A total of 48% of patients had symptoms of moderate anxiety, and 33% had symptoms of severe anxiety. Based on the multivariate analysis, factors associated with a lower risk of anxiety symptoms included higher household income (OR -2.21 (95 CI: -1.35, -3.07)) and having reliable social support (OR -2.93 (95% CI: -2.25, -3.61)).
The prevalence of anxiety symptoms is very high among newly diagnosed breast cancer patients. Anxiety is more likely to develop in patients from low-income households and those without reliable social support.
乳腺癌的诊断与较高的心理困扰相关。目前,缺乏研究检查哈萨克斯坦新诊断乳腺癌患者的焦虑症患病率。
本研究旨在评估新诊断乳腺癌女性中焦虑症状的平均患病率及其相关社会人口学和临床因素,并确定焦虑风险的独立预测因素。
对阿拉木图肿瘤研究所的 162 名新诊断乳腺癌患者进行了分析。使用结构化问卷收集社会人口学和临床信息以及贝克焦虑量表的数据。此外,还使用多元回归分析来建立焦虑风险与独立预测因素之间的关系模型。
患者的平均年龄为 54.41 岁(SD=8.1;最小-最大:32-75)。大多数患者已婚(52%)、有职业或自营职业(51%)、有子女(91%)、有学士或研究生学历(50%)、居住在城市地区(54%)、不饮酒(41%)、不吸烟(67%)、不参加体育活动(54%)且有社会支持(91%)。共有 48%的患者有中度焦虑症状,33%的患者有重度焦虑症状。基于多变量分析,与焦虑症状风险降低相关的因素包括较高的家庭收入(OR-2.21(95%CI:-1.35,-3.07))和可靠的社会支持(OR-2.93(95%CI:-2.25,-3.61))。
新诊断乳腺癌患者的焦虑症状患病率非常高。收入较低的家庭和缺乏可靠社会支持的患者更有可能出现焦虑。